SPECT can be used to complement any gamma imaging study, where a true 3D representation can be helpful, such as tumor imaging, infection (
leukocyte) imaging, thyroid imaging or
bone scintigraphy. Because SPECT permits accurate localisation in 3D space, it can be used to provide information about localised function in internal organs, such as functional cardiac or brain imaging.
Myocardial perfusion imaging Myocardial perfusion imaging (MPI) is a form of functional cardiac imaging, used for the diagnosis of
ischemic heart disease. The underlying principle is that under conditions of stress, diseased
myocardium receives less blood flow than normal myocardium. MPI is one of several types of
cardiac stress test. A cardiac specific radiopharmaceutical is administered, e.g., 99mTc-
tetrofosmin (Myoview, GE healthcare), 99m
Tc-sestamibi (Cardiolite, Bristol-Myers Squibb) or
Thallium-201 chloride. Following this, the heart rate is raised to induce myocardial stress, either by exercise on a
treadmill or pharmacologically with
adenosine,
dobutamine, or
dipyridamole (
aminophylline can be used to reverse the effects of dipyridamole). SPECT imaging performed after stress reveals the distribution of the radiopharmaceutical, and therefore the relative blood flow to the different regions of the myocardium. Diagnosis is made by comparing stress images to a further set of images obtained at rest which are normally acquired prior to the stress images. MPI has been demonstrated to have an overall accuracy of about 83% (
sensitivity: 85%;
specificity: 72%) (in a review, not exclusively of SPECT MPI), and is comparable with (or better than) other non-invasive tests for ischemic heart disease.
Functional brain imaging Usually, the gamma-emitting tracer used in functional brain imaging is
technetium (99mTc) exametazime.
99mTc, which has a six-hour half-life, is a metastable
nuclear isomer that emits gamma rays detectable by a gamma camera. Attaching it to exametazime allows it to be taken up by brain tissue in a manner proportional to brain blood flow, in turn allowing
cerebral blood flow to be assessed with the nuclear gamma camera. Because blood flow in the brain is tightly coupled to local brain metabolism and energy use, the 99mTc-exametazime tracer (as well as the similar 99mTc-EC tracer) is used to assess brain metabolism regionally, in an attempt to diagnose and differentiate potential causal pathologies of
dementia. Meta-analysis of many reported studies suggests that SPECT with this tracer is about 74% sensitive at diagnosing Alzheimer's disease versus 81% sensitivity for clinical examination (such as
cognitive testing). More recent studies have shown the accuracy of SPECT in Alzheimer's diagnosis may be as high as 88%. In meta-analysis, SPECT was superior to clinical examination and clinical criteria (91% vs. 70%) in its ability to differentiate Alzheimer's disease from vascular dementias. This latter ability relates to SPECT's imaging of local metabolism of the brain, in which the patchy loss of cortical metabolism seen in multiple strokes differs clearly from the more even or "smooth" loss of non-occipital cortical brain function typical of Alzheimer's disease. Another review article, published in 2012, showed that multi-headed SPECT cameras with quantitative analysis result in an overall sensitivity of 84-89% and an overall specificity of 83-89% in cross-sectional studies and sensitivity of 82-96% and specificity of 83-89% for longitudinal studies of dementia. 99mTc-exametazime SPECT scanning competes with
fludeoxyglucose (FDG)
PET scanning of the brain, which works to assess regional brain glucose metabolism, to provide very similar information about local brain damage from many processes. SPECT is more widely available, because the radioisotope used is longer-lasting and far less expensive in SPECT, and the gamma-scanning equipment is less expensive as well. While 99mTc is extracted from relatively simple
technetium-99m generators, which are delivered to hospitals and scanning centers weekly to supply fresh radioisotope, FDG PET relies on FDG, which is made in an expensive medical
cyclotron and "hot lab" (automated chemistry lab for radiopharmaceutical manufacture), and then delivered immediately to scanning sites because of the natural short 110-minute half-life of
fluorine-18.
Applications in nuclear technology In the nuclear power sector, the SPECT technique can be applied to image radioisotope distributions in irradiated nuclear fuels. Due to the irradiation of nuclear fuel (e.g. uranium) with neutrons in a nuclear reactor, a wide array of gamma-emitting radionuclides are naturally produced in the fuel, such as fission products (
cesium-137,
barium-140 and
europium-154) and activation products (
chromium-51 and
cobalt-58). These may be imaged using SPECT in order to verify the presence of fuel rods in a stored fuel assembly for
IAEA safeguards purposes, to validate predictions of core simulation codes, or to study the behavior of the nuclear fuel in normal operation, or in accident scenarios. ==Reconstruction==